Clinical Trial Update: A Study to Compare Early Use of Vinorelbine and Maintenance Therapy for Patients With High Risk Rhabdomyosarcoma [Phase 3]

View source ↗

Summary

Phase 3 study by the Children's Oncology Group comparing early use of vinorelbine and maintenance therapy for high-risk rhabdomyosarcoma is currently active but…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alveolar Rhabdomyosarcoma
• Botryoid-type Embryonal Rhabdomyosarcoma
• Embryonal Rhabdomyosarcoma
• Rhabdomyosarcoma
• Spindle Cell Sclerosing Rhabdomyosarcoma
• Spindle-cell Rhabdomyosarcoma

Drugs mentioned

• Navelbine (vinorelbine)
• Vinorelbine (Vinorelbine)

Snippet

Sponsor: Children's Oncology Group | Conditions: Alveolar Rhabdomyosarcoma, Botryoid-Type Embryonal Rhabdomyosarcoma | Phase 3 | Status: ACTIVE_NOT_RECRUITING